Dr Ben Bray joins team as new principal
LCP has appointed Dr Ben Bray, a medical doctor and epidemiologist with a clinical background in nephrology and public health, as a principal in its health analytics team.
Dr Bray will bring over 10 years of experience in academia and industry in health data science, as well as deep-rooted expertise in designing and executing scientific studies using real-world health data.
He has also developed advanced analytics solutions to support healthcare providers and life sciences companies.
His previous roles have included head of epidemiology for Data Science and principal in genomics at a leading contract research organisation.
He was also clinical lead for stroke at the National Cardiovascular Intelligence Network of Public Health England, and clinical advisor to NHS England and NHS Kidney Care.
And he is an honorary senior clinical lecturer at King’s College London, where he works on research into machine learning analytics using large health databases.
The r appointment will further bolster the expertise of the health analytics team at LCP, which has grown substantially since it was established in 2020.
Andrew Thompson, Mei Chain, and Robert King all joined in recent months, bringing with them specialist skills across the health spectrum.
The team’s data-driven approach combines actuarial, statistical, and machine learning expertise to bring to light the health needs of populations.
To date, the team has developed cutting-edge analysis and insights around the UK population’s health and multimorbidity linked to type 2 diabetes.
And it has developed a corresponding Health Index Tracker and Type 2 Diabetes Tracker and has built explorers of COVID-19 prevalence and waiting list variances across England.
Dr Jonathan Pearson-Stuttard, head of the health analytics team, said: “ We are delighted that Ben has joined us at this important and exciting time in our growth.
“Our first year has confirmed the overwhelming need to bring clarity to increasingly-complex health demands from ageing populations with increasing multimorbidity.
“Ben’s expertise across industry, academia, and clinical medicine gives him a unique perspective to leverage the latest data and our cutting-edge modelling to put timely, actionable data in the hands of key stakeholders to address these challenges and drive a healthier tomorrow.”
Dr Bray added: “I am very excited to be joining the team, which has advanced impressively over the past 12 months, and I look forward to working alongside them to help build on the work to date in supporting decision makers to drive better health outcomes.”